Transdermal drug delivery

Nature Biotechnology

Volumn 26, Issue 11, 2008, Pages 1261-1268

  Prausnitz, Mark R ^a   Langer, Robert ^b  

^a Georgia Institute of Technology   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION; ACOUSTIC WAVES; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; ELECTROPHORESIS; ELECTROTHERAPEUTICS; SUPRAMOLECULAR CHEMISTRY; ULTRASONICS;

BARRIER LAYERS; CHEMICAL ENHANCERS; CLINICAL TRIALS; CLINICAL USES; DELIVERY RATES; DELIVERY SYSTEMS; ELECTROPORATION; INFLUENZA VACCINES; MEDICAL PRACTICES; MICRO NEEDLES; ORAL DELIVERIES; PARATHYROID HORMONES; REAL TIMES; STRATUM CORNEUM; TRANSDERMAL DELIVERIES; TRANSDERMAL DRUG DELIVERIES;

REAL TIME SYSTEMS;

2 NONYL 1,3 DIOXOLANE; CLONIDINE; ESTRADIOL; ESTRADIOL PLUS LEVONORGESTREL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; FENTANYL; GLYCERYL TRINITRATE; INSULIN; LAUROCAPRAM; LIDOCAINE; METHYLPHENIDATE; NICOTINE; OXYBUTYNIN; PARATHYROID HORMONE; RIVASTIGMINE; ROTIGOTINE; SCOPOLAMINE; SELEGILINE; TESTOSTERONE;

DRUG INDUSTRY; DRUG TRANSPORT; ELECTROPORATION; HUMAN; INFLUENZA VACCINATION; IONTOPHORESIS; MEDICAL PRACTICE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS; SKIN;

EID: 55749108348     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1504     Document Type: Review

References (63)

1. Guy, R.H. & Hadgraft, J. (eds.) Transdermal Drug Delivery (Marcel Dekker, New York; 2003).
2. Williams, A. Transdermal and Topical Drug Delivery (Pharmaceutical Press, London; 2003).
3. Prausnitz, M.R., Mitragotri, S. & Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3, 115-124 (2004).
4. Bronaugh, R.L. & Maibach, H.I. (eds.) Percutaneous Absorption, edn. 4 (Marcel Dekker, New York; 2005).
5. Miller, M.A. & Pisani, E. The cost of unsafe injections. Bull. World Health Organ. 77, 808-811 (1999).
6. Foldvari, M., Babiuk, S. & Badea, I. DNA delivery for vaccination and therapeutics through the skin. Curr. Drug Deliv. 3, 17-28 (2006).
7. Glenn, G.M. & Kenney, R.T. Mass vaccination: solutions in the skin. Curr. Top. Microbiol. Immunol. 304, 247-268 (2006).
8. Mayes, S. & Ferrone, M. Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain. Ann. Pharmacother. 40, 2178-2186 (2006).
9. Sieg, A., Guy, R.H. & Delgado-Charro, M.B. Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol. Ther. 7, 174-197 (2005).
10. Morgan, T.M., Reed, B.L. & Finnin, B.C. Enhanced skin permeation of sex hormones with novel topical spray vehicles. J. Pharm. Sci. 87, 1213-1218 (1998).
11. Williams, A.C. & Barry, B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 56, 603-618 (2004).
12. Smith, E.W. & Maibach, H.I. (eds.) Percutaneous Penetration Enhancers (Taylor and Francis Group, Boca Raton, FL; 2006).
13. Karande, P., Jain, A., Ergun, K., Kispersky, V. & Mitragotri, S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc. Natl. Acad. Sci. USA 102, 4688-4693 (2005).
14. Kogan, A. & Garti, N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123-126, 369-385 (2006).
15. Touitou, E. & Godin, B. Vesicular carriers for enhanced delivery through the skin. in Enhancement in Drug Delivery (eds. Touitou, E. & Barry, B.) 255-278 (CRC Press, Boca Raton, FL; 2007).
16. Sloan, K.B., Wasdo, S.C. & Rautio, J. Design for optimized topical delivery: Prodrugs and a paradigm change. Pharm. Res. 23, 2729-2747 (2006).
17. Kiptoo, P.K., Hamad, M.O., Crooks, P.A. & Stinchcomb, A.L. Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion. J. Control. Release 113, 137-145 (2006).
18. Banga, A.K. Electrically-Assisted Transdermal and Topical Drug Delivery (Taylor & Francis, London; 1998).
19. Kalia, Y.N., Naik, A., Garrison, J. & Guy, R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56, 619-658 (2004).
20. Pikal, M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 46, 281-305 (2001).
21. Subramony, J.A., Sharma, A. & Phipps, J.B. Microprocessor controlled transdermal drug delivery. Int. J. Pharm. 317, 1-6 (2006).
22. Prausnitz, M.R. The effects of electric current applied to the skin: a review for transdermal drug delivery. Adv. Drug Deliv. Rev. 18, 395-425 (1996).
23. Zempsky, W.T., Sullivan, J., Paulson, D.M. & Hoath, S.B. Evaluation of a low-dose lidocaine iontophoresis system for topical anesthesia in adults and children: a randomized, controlled trial. Clin. Ther. 26, 1110-1119 (2004).
24. Beauchamp, M. & Lands, L.C. Sweat-testing: a review of current technical requirements. Pediatr. Pulmonol. 39, 507-511 (2005).
25. Kreyden, O.P. Iontophoresis for palmoplantar hyperhidrosis. J. Cosmet. Dermatol. 3, 211-214 (2004).
26. Tamada, J.A. et al. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. J. Am. Med. Assoc. 282, 1839-1844 (1999).
27. Chaturvedula, A. et al. Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery. Pharm. Res. 22, 1313-1319 (2005).
28. Morrel, E.M., Spruance, S.L. & Goldberg, D.I. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial. Clin. Infect. Dis. 43, 460-467 (2006).
29. Machet, L. & Boucaud, A. Phonophoresis: efficiency, mechanisms and skin tolerance. Int. J. Pharm. 243, 1-15 (2002).
30. Wu, J. & Nyborg, W. (eds.) Emerging Therapeutic Ultrasound (Imperial College Press, London; 2006).
31. Arora, A., Prausnitz, M.R. & Mitragotri, S. Micro-scale devices for transdermal drug delivery. Int. J. Pharm. published online, doi:10.1016/j.ijpharm.2008.08.032 (30 August 2008).
32. Karande, P., Jain, A. & Mitragotri, S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat. Biotechnol. 22, 192-197 (2004).
33. Chen, Y. et al. Transdermal protein delivery by a coadministered peptide identified via phage display. Nat. Biotechnol. 24, 455-460 (2006).
34. Kim, Y.C., Ludovice, P.J. & Prausnitz, M.R. Transdermal delivery enhanced by magainin pore-forming peptide. J. Control. Release 122, 375-383 (2007).
35. Rothbard, J.B. et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6, 1253-1257 (2000).
36. Denet, A.R., Vanbever, R. & Preat, V. Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev. 56, 659-674 (2004).
37. Li, S. (ed.) Electroporation Protocols: Preclinical and Clinical Gene Medicine (Humana Press, Totowa, NJ; 2008).
38. Zhao, Y.L. et al. Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 24, 1282-1290 (2006).
39. Pliquett, U. & Weaver, J.C. Feasibility of an electrode-reservoir device for transdermal drug delivery by noninvasive skin electroporation. IEEE Trans. Biomed. Eng. 54, 536-538 (2007).
40. Ogura, M., Paliwal, S. & Mitragotri, S. Low-frequency sonophoresis: Current status and future prospects. Adv. Drug Deliv. Rev. 60, 1218-1223 (2008).
41. Paliwal, S., Menon, G.K. & Mitragotri, S. Low-frequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots. J. Invest. Dermatol. 126, 1095-1101 (2006).
42. Becker, B.M. et al. Ultrasound with topical anesthetic rapidly decreases pain of intravenous cannulation. Acad. Emerg. Med. 12, 289-295 (2005).
43. Park, E.J., Werner, J. & Smith, N.B. Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm. Res. 24, 1396-1401 (2007).
44. Chuang, H., Taylor, E. & Davison, T.W. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin. Diabetes Technol. Ther. 6, 21-30 (2004).
45. Doukas, A.G. & Kollias, N. Transdermal drug delivery with a pressure wave. Adv. Drug Deliv. Rev. 56, 559-579 (2004).
46. Sivamani, R.K., Liepmann, D. & Maibach, H.I. Microneedles and transdermal applications. Expert Opin. Drug Deliv. 4, 19-25 (2007).
47. Prausnitz, M.R., Gill, H.S. & Park, J.-H. Microneedles for Drug Delivery in Modified Release Drug Delivery vol. 2 (eds. Rathbone, M.J., Hadgraft, J., Roberts, M.S. & Lane, M.E.) 1295-309 (Informa Healthcare, New York; 2008).
48. Gill, H.S. & Prausnitz, M.R. Coated microneedles for transdermal delivery. J. Control. Release 117, 227-237 (2007).
49. Lee, J.W., Park, J.H. & Prausnitz, M.R. Dissolving microneedles for transdermal drug delivery. Biomaterials 29, 2113-2124 (2008).
50. Wermeling, D.P. et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc. Natl. Acad. Sci. USA 105, 2058-2063 (2008).
51. Prausnitz, M.R., Mikszta, J.A., Cormier, M. & Andrianov, A.K. Microneedle-based vaccines. Curr. Top. Microbiol. Immunol. (in the press).
52. Laurent, P.E. et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25, 8833-8842 (2007).
53. Bramson, J. et al. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther. 10, 251-260 (2003).
54. Levin, G. et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm. Res. 22, 550-555 (2005).
55. Park, J.H., Lee, J.W., Kim, Y.C. & Prausnitz, M.R. The effect of heat on skin permeability. Int. J. Pharm. 359, 94-103 (2008).
56. Badkar, A.V., Smith, A.M., Eppstein, J.A. & Banga, A.K. Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm. Res. 24, 1389-1395 (2007).
57. Herndon, T.O., Gonzalez, S., Gowrishankar, T., Anderson, R.R. & Weaver, J.C. Transdermal microconduits by microscission for drug delivery and sample acquisition. BMC Med. 2, 12 (2004).
58. Glenn, G.M. et al. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Rev. Vaccines 6, 809-819 (2007).
59. Mitragotri, S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res. 17, 1354-1359 (2000).
60. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations, edn. 27 (Department of Health and Human Services, Rockville, MD; 2007).
61. Bouwstra, J.A. et al. Water distribution and related morphology in human stratum corneum at different hydration levels. J. Invest. Dermatol. 120, 750-758 (2003).
62. Weniger, B.G. & Papania, M. Alternative vaccine delivery methods. in Vaccines, edn. 5 (eds. Plotkn, S., Orenstein, W. & Offit, P.) 1357-1392 (Elsevier, Philadelphia; 2008).
63. Venkatraman, S. & Gale, R. Skin adhesives and skin adhesion. 1. Transdermal drug delivery systems. Biomaterials 19, 1119-1136 (1998).